Genizer's NanoMixer is a microfluidic mixer designed for laboratory use. This nanomixer prepares mRNA, DNA, siRNA delivery systems, and various other nanoparticles. It is an electronic device that ...
Microfluidic mixing techniques and devices are pivotal in advancing applications ranging from chemical synthesis to biomedical diagnostics. In these systems, liquids or gases are combined in channels ...
Layered drug nanoparticles can now be produced efficiently and at scale using a microfluidic method that eliminates purification and improves consistency. Since its adaptation to nanoscale materials, ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
The primary components of LNP–RNA are ionizable lipids, cholesterol, PEGylated lipids, and phospholipids, which together form the nanoparticle, along with the active pharmaceutical ingredient, RNA.
Microfluidics involves fluid manipulation and control at a submillimeter scale within microfabricated channels etched on a chip, forming a miniature laboratory capable of performing complex analytical ...
CAMBRIDGE, MA -- Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian cancer. These particles can be targeted directly to tumors, ...
When synthesizing nanoscale liposomes, the ability to control vesicle size helps define their pharmaceutical properties. Conventional microfluidic liposome synthesis methods, however, are limited in ...
A new microfluidic device promises to revolutionize kidney disease screening by enabling rapid, accurate, and low-cost testing of creatinine levels in urine. Creatinine is a key biomarker used to ...
3D printing creates hydrophobic barriers in hydrophilic paper, guiding liquids along precise paths for controlled mixing, gradients, and two-phase separation. (Nanowerk News) Filter paper plays ...
Lipopolyplexes are emerging as effective, second-generation, nonviral vectors to deliver gene therapies, yet there are challenges. To resolve them, researchers at the University of Milan have ...